U.S. Mrna Synthesis Raw Materials Market Size & Outlook
U.S. mrna synthesis raw materials market, 2018-2030 (US$M)
Related Markets
U.S. mrna synthesis raw materials market highlights
- The U.S. mrna synthesis raw materials market generated a revenue of USD 842.7 million in 2023 and is expected to reach USD 976.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 2.1% from 2024 to 2030.
- In terms of segment, capping agents was the largest revenue generating type in 2023.
- Capping Agents is the most lucrative type segment registering the fastest growth during the forecast period.
Mrna synthesis raw materials market data book summary
| Market revenue in 2023 | USD 842.7 million |
| Market revenue in 2030 | USD 976.2 million |
| Growth rate | 2.1% (CAGR from 2023 to 2030) |
| Largest segment | Capping agents |
| Fastest growing segment | Capping Agents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capping Agents, Nucleotides, Plasmid DNA, Enzymes |
| Key market players worldwide | Roche Holding AG, Merck KGaA, Thermo Fisher Scientific Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, New England Biolabs, Creative-Biolabs, Jena Bioscience, YEASEN Biotechnology, BOC Sciences, Hongene Biotechnology |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.4% of the global mrna synthesis raw materials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. mrna synthesis raw materials market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 233.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Synthesis Raw Materials Market Scope
MRNA Synthesis Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. mrna synthesis raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna synthesis raw materials market will help companies and investors design strategic landscapes.
Capping agents was the largest segment with a revenue share of 41.02% in 2023. Horizon Databook has segmented the U.S. mrna synthesis raw materials market based on capping agents, nucleotides, plasmid dna, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
A large number of market players in the U.S. are engaged in continuous development of advanced mRNA synthesis raw materials for research. Presence of innovators and major market players has resulted in higher product penetration in the country.
Furthermore, presence of a structured environment for usage and approvals of mRNA-based therapeutics & vaccines and local presence of key companies, such as BOC Sciences, Thermo Fisher Scientific, New England Biolabs, and Maravai LifeSciences; and a comprehensive informatics network within the country, are boosting market growth.
For instance, in August 2022, New England Biolabs introduced a novel Faustovirus Capping Enzyme for enzymatic capping of mRNA to support mRNA therapeutic manufacturing requirements.
Reasons to subscribe to U.S. mrna synthesis raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. mrna synthesis raw materials market databook
-
Our clientele includes a mix of mrna synthesis raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. mrna synthesis raw materials market , including forecasts for subscribers. This country databook contains high-level insights into U.S. mrna synthesis raw materials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. mrna synthesis raw materials market size, by type, 2018-2030 (US$M)
U.S. MRNA Synthesis Raw Materials Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
